Precigen Inc (NAS:PGEN)
$ 0.9758 0.0244 (2.56%) Market Cap: 285.56 Mil Enterprise Value: 272.37 Mil PE Ratio: 0 PB Ratio: 5.71 GF Score: 46/100

Precigen Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2022 / 08:45PM GMT
Release Date Price: $3.12 (-4.59%)
Eric William Joseph
JPMorgan Chase & Co, Research Division - VP & Senior Analyst

Good afternoon, and thanks for tuning into the 40th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst with the firm.

Our next presenting company is Precigen. And it's my pleasure to welcome Helen Sabzevari to talk to us a little bit about the company. There is a Q&A session after the presentation. So just click the icon, and I'll work in questions where appropriate.

With that, Helen, thanks very much for sharing some of your time with us to speak.

Helen Sabzevari
Precigen, Inc. - President, CEO & Director

Absolutely. Thank you so much, Eric, for having us. And we are really -- it's a pleasure always for us to present at JPMorgan presentation series. So with that, what I would like to do is, today, take a few minutes to take you through the updates that we had presented over the last year and also the goals and what we are going to do in the upcoming year. With that in mind, if we move to the second slide is our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot